Updated on 2022/07/29

写真a

 
SHIBATA Masahiro
 
Organization
Nagoya University Hospital Breast and Endocrine Surgery Lecturer
Graduate School
Graduate School of Medicine
Title
Lecturer
Contact information
メールアドレス
External link

Degree 2

  1. 学士 ( 2005.3   名古屋大学 ) 

  2. 博士(医学) ( 2018.3   名古屋大学 ) 

Research Interests 7

  1. Breast cancer, Thyroid cancer, Adrenal tumor, Parathyroid, Biomarker

  2. Parathyroid

  3. Breast cancer

  4. Biomarker

  5. バイオマーカー

  6. Adrenal tumor

  7. Thyroid cancer

Research Areas 1

  1. Life Science / General surgery and pediatric surgery  / 乳腺・内分泌外科分野

Research History 9

  1. Nagoya University   Lecturer

    2022.8

  2. Nagoya University   Nagoya University Hospital Breast and Endocrine Surgery   Assistant Professor

    2020.4 - 2022.7

  3. Nagoya University   Nagoya University Hospital Breast and Endocrine Surgery   Assistant professor of hospital

    2018.10 - 2020.3

  4. Johns Hopkins University   Department of Otolaryngology   Postdoctoral Fellow

    2016.10 - 2018.9

  5. Nagoya University Hospital   Department of Breast and Endocrine Surgery   Clinical Fellow

    2015.1 - 2016.9

  6. Toyohashi Medical Center   Department of Surgery   Staff member

    2014.4 - 2014.12

  7. Fujita Health University   Department of Endocrine Surgery   Assistant Professor

    2012.1 - 2014.3

  8. Yokkaichi Municipal Hospital   Department of Surgery   Clinical Fellow

    2007.4 - 2011.12

      More details

    Country:Japan

  9. Yokkaichi Municipal Hospital   Rsident

    2005.4 - 2007.3

      More details

    Country:Japan

▼display all

Education 2

  1. Nagoya University   Graduate School, Division of Medical Sciences

    2014.4 - 2018.3

      More details

    Country: Japan

  2. Nagoya University   Faculty of Medicine

    1999.4 - 2005.3

      More details

    Country: Japan

Professional Memberships 12

  1. Japan Surgical Society

  2. Japanese Breast Cancer Society

  3. Japan Association of Breast Cancer Screening

  4. Japan Association of Endocrine Surgeons

  5. Japan Endocrine Society

  6. Japan Association of Breast and Thyroid Sonology

  7. Japan Thyroid Association

  8. Japan Society of Clinical Oncology

  9. Japan Society for Endoscopic Surgery

  10. Japan Society for Oriental Medicine

  11. Japan Surgical Association

  12. Japan Thyroid Association

▼display all

Awards 2

  1. 研究奨励賞

    2022.6   日本内分泌外科学会   高リスク乳頭癌の遺伝子発現プロファイリング解明を目指した研究

     More details

    Award type:Award from Japanese society, conference, symposium, etc.  Country:Japan

  2. 研究奨励賞

    2021.7   日本乳癌学会   乳癌における新規バイオマーカー、治療標的分子の発見に関する研究

     More details

    Award type:Award from Japanese society, conference, symposium, etc.  Country:Japan

 

Papers 35

  1. A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy.

    Shibata M, Ham K, Hoque MO

    International journal of cancer   Vol. 143 ( 9 ) page: 2133-2144   2018.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/ijc.31561

    PubMed

  2. Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer.

    Shibata M, Hoque MO

    Cancers   Vol. 11 ( 5 )   2019.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/cancers11050732

    PubMed

  3. RASEF expression correlates with hormone receptor status in breast cancer

    Shibata M.

    Oncology Letters   Vol. 16 ( 6 ) page: 7223-7230   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/ol.2018.9542

    Scopus

  4. Development of biomarkers for real precision medicine.

    Shibata M, Hoque MO

    Translational lung cancer research   Vol. 7 ( Suppl 3 ) page: S228-S231   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.21037/tlcr.2018.08.07

    PubMed

  5. Pattern-Specific Transcriptomics Identifies ASGR2 as a Predictor of Hematogenous Recurrence of Gastric Cancer

    Tanaka Haruyoshi, Kanda Mitsuro, Miwa Takashi, Tanaka Chie, Kobayashi Daisuke, Umeda Shinichi, Shibata Masahiro, Suenaga Masaya, Hattori Norifumi, Hayashi Masamichi, Iwata Naoki, Yamada Suguru, Nakayama Goro, Fujiwara Michitaka, Kodera Yasuhiro

    MOLECULAR CANCER RESEARCH   Vol. 16 ( 9 ) page: 1420-1429   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1158/1541-7786.MCR-17-0467

    Web of Science

    Scopus

    PubMed

  6. Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in Japan

    Morita Sachi, Kikumori Toyone, Tsunoda Nobuyuki, Inaishi Takahiro, Adachi Yayoi, Ota Akiko, Shibata Masahiro, Matsuoka Ayumu, Nakanishi Kenichi, Takeuchi Dai, Mizutani Takefumi, Shimokata Tomoya, Hayashi Hironori, Maeda Osamu, Ando Yuichi

    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   Vol. 23 ( 1 ) page: 195-200   2018.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10147-017-1177-z

    Web of Science

    Scopus

    PubMed

  7. Obesity does not affect peri- and postoperative outcomes of transabdominal laparoscopic adrenalectomy

    Inaishi Takahiro, Kikumori Toyone, Takeuchi Dai, Ishihara Hiromasa, Miyajima Noriyuki, Shibata Masahiro, Takano Yuko, Nakanishi Kenichi, Noda Sumiyo, Kodera Yasuhiro

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 80 ( 1 ) page: 21-28   2018.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18999/nagjms.80.1.21

    Web of Science

    Scopus

    PubMed

  8. Synchronous bilateral pheochromocytomas and paraganglioma with novel germline mutation in MAX: a case report

    Shibata Masahiro, Inaishi Takahiro, Miyajima Noriyuki, Adachi Yayoi, Takano Yuko, Nakanishi Kenichi, Takeuchi Dai, Noda Sumiyo, Aita Yuichi, Takekoshi Kazuhiro, Kodera Yasuhiro, Kikumori Toyone

    SURGICAL CASE REPORTS   Vol. 3 ( 1 ) page: 131   2017.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s40792-017-0408-x

    Web of Science

    PubMed

  9. Overexpression of Derlin 3 is associated with malignant phenotype of breast cancer cells

    Shibata Masahiro, Kanda Mitsuro, Tanaka Haruyoshi, Umeda Shinichi, Miwa Takashi, Shimizu Dai, Hayashi Masamichi, Inaishi Takahiro, Miyajima Noriyuki, Adachi Yayoi, Takano Yuko, Nakanishi Kenichi, Takeuchi Dai, Noda Sumiyo, Kodera Yasuhiro, Kikumori Toyone

    ONCOLOGY REPORTS   Vol. 38 ( 3 ) page: 1760-1766   2017.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/or.2017.5800

    Web of Science

    Scopus

    PubMed

  10. Expression of regulatory factor X1 can predict the prognosis of breast cancer

    Shibata Masahiro, Kanda Mitsuro, Shimizu Dai, Tanaka Haruyoshi, Umeda Shinichi, Hayashi Masamichi, Inaishi Takahiro, Miyajima Noriyuki, Adachi Yayoi, Takano Yuko, Nakanishi Kenichi, Takeuchi Dai, Noda Sumiyo, Kodera Yasuhiro, Kikumori Toyone

    ONCOLOGY LETTERS   Vol. 13 ( 6 ) page: 4334-4340   2017.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/ol.2017.6005

    Web of Science

    Scopus

    PubMed

  11. The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy

    Shimizu Dai, Kanda Mitsuro, Sugimoto Hiroyuki, Shibata Masahiro, Tanaka Haruyoshi, Takami Hideki, Iwata Naoki, Hayashi Masamichi, Tanaka Chie, Kobayashi Daisuke, Yamada Suguru, Nakayama Goro, Koike Masahiko, Fujiwara Michitaka, Fujii Tsutomu, Kodera Yasuhiro

    INTERNATIONAL JOURNAL OF ONCOLOGY   Vol. 50 ( 2 ) page: 381-386   2017.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/ijo.2017.3833

    Web of Science

    Scopus

    PubMed

  12. Platelet isoform of phosphofructokinase accelerates malignant features in breast cancer

    Inaishi Takahiro, Shibata Masahiro, Ichikawa Takahiro, Kanda Mitsuro, Hayashi Masamichi, Soeda Ikumi, Takeuchi Dai, Takano Yuko, Tsunoda Nobuyuki, Kodera Yasuhiro, Kikumori Toyone

    ONCOLOGY REPORTS   Vol. 47 ( 1 )   2022.1

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Oncology reports  

    The platelet isoform of phosphofructokinase (PFKP) is one of the key enzymes in the glycolytic pathway. PFKP is highly expressed in several cancers, and it has been reported to be involved in the progression of cancer cells. However, its oncological role in breast cancer (BC) remains unclear. The present study aimed to evaluate the function of PFKP in BC cells and its expression level in patients with BC. Firstly, the mRNA and protein expression of PFKP was evaluated in BC and non‑cancerous mammary cell lines. Polymerase chain reaction (PCR) array analysis was conducted to evaluate the correlation between PFKP and 84 cancer‑related genes. Then, PFKP knockdown was conducted using small interfering RNA, and cell proliferation, invasiveness and migration were analyzed. Furthermore, the association between PFKP mRNA expression and clinicopathological factors was investigated in 167 patients with BC. PFKP was highly expressed in estrogen receptor‑negative and human epidermal growth factor receptor 2‑negative BC cell lines. PCR array analysis demonstrated that the expression level of PFKP was significantly correlated with that of transforming growth factor‑β1 and MYC proto‑oncogene. PFKP knockdown significantly decreased the proliferation and invasiveness of MCF7, SK‑BR‑3, and MDA‑MB‑231 cells. Furthermore, cell migration was inhibited in SK‑BR‑3 and MDA‑MB‑231 cells. In the clinical specimens, patients with T2/T3/T4, lymph node metastasis, or stage II/III/IV exhibited higher expression of PFKP mRNA than patients with less severe disease. In conclusion, the present findings indicated that PFKP is involved in promoting tumor‑progressive oncological roles in BC cells across different subtypes and is considered a possible novel therapeutic target for BC.

    DOI: 10.3892/or.2021.8220

    Web of Science

    Scopus

    PubMed

  13. S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model

    Miyajima Noriyuki, Eissa Ibrahim Ragab, Abdelmoneim Mohamed, Naoe Yoshinori, Ichinose Toru, Matsumura Shigeru, Bustos-Villalobos Itzel, Mukoyama Nobuaki, Morimoto Daishi, Shibata Masahiro, Takeuchi Dai, Tsunoda Nobuyuki, Kikumori Toyone, Tanaka Maki, Kodera Yasuhiro, Kasuya Hideki

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 83 ( 4 ) page: 683 - 696   2021.11

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Nagoya Journal of Medical Science  

    Canerpaturev (C-REV) is a highly attenuated, replication-competent, mutant strain of oncolytic herpes simplex virus type 1 that may be an effective new cancer treatment option. S-1, an oral formulation containing the 5-fluorouracil (5-FU) prodrug tegafur and the two enzyme modulators gimeracil and oteracil, is used as a key chemotherapeutic agent for metastatic recurrent breast cancer. Although the antitumor effects of oncolytic viruses combined with 5-FU in vivo have been reported, the detailed mechanisms are unknown. Here, we investigated the antitumor mechanism of the combination of C-REV and S-1 in triple-negative breast cancer (TNBC) in the context of tumor immunity. The combined effect of C-REV and S-1 was evaluated in a bilateral tumor model of murine TNBC 4T1 in vivo. S-1 enhanced the TNBC growth inhibitory effects of C-REV, and decreased the number of tumor-infiltrating, myeloid-derived suppressor cells (MDSCs), which suppress both innate and adaptive immune responses. Moreover, C-REV alone and in combination with S-1 significantly increased the number of CD8+ T cells in the tumor and the production of interferon γ (IFNγ) from these cells. Our findings indicate that C-REV suppresses TNBC tumor growth by inducing the expansion of effector CD8+ T cell subsets in tumors in which S-1 can inhibit MDSC function. Our study suggests that MDSCs may be an important cellular target for breast cancer treatment. The combination of C-REV and S-1 is a new approach that might be directly translated into future clinical trials against TNBC.

    DOI: 10.18999/nagjms.83.4.683

    Web of Science

    Scopus

    PubMed

  14. Authors' Reply: Development of a Rapid Intraoperative Point-of-Care Method Using Tissue Suspension to Differentiate Parathyroid Tissue: A Possible Substitute for Frozen Sections

    Kikumori Toyone, Shibata Masahiro, Takeuchi Dai

    WORLD JOURNAL OF SURGERY   Vol. 45 ( 11 ) page: 3476 - 3477   2021.11

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:World Journal of Surgery  

    DOI: 10.1007/s00268-021-06314-x

    Web of Science

    Scopus

    PubMed

  15. <i>Synaptotagmin 13</i> Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer.

    Ichikawa T, Shibata M, Inaishi T, Soeda I, Kanda M, Hayashi M, Takano Y, Takeuchi D, Tsunoda N, Kodera Y, Kikumori T

    Current oncology (Toronto, Ont.)   Vol. 28 ( 5 ) page: 4080 - 4092   2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/curroncol28050346

    PubMed

  16. Identifying the tumor-progressive gene expression profile in high-risk papillary thyroid cancer

    Shibata Masahiro, Inaishi Takahiro, Ichikawa Takahiro, Shimizu Dai, Soeda Ikumi, Takano Yuko, Takeuchi Dai, Tsunoda Nobuyuki, Kikumori Toyone

    SURGERY TODAY   Vol. 51 ( 10 ) page: 1703 - 1712   2021.10

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Surgery Today  

    Purpose: Papillary thyroid cancer (PTC) is generally associated with a favorable prognosis. However, some patients have fatal disease, with locally infiltrating tumors or progressive distant metastases; yet few studies have investigated the characteristics of the tumor-progressive gene expression profile in advanced PTC. We conducted this study to clarify the gene expression status in advanced PTC and identify candidate molecules for prognostic biomarkers. Methods: We analyzed 740 tumor-progressive gene expression levels from formalin-fixed paraffin-embedded blocks of samples from six patients with low-risk PTC and six patients with high-risk PTC, using the nCounter PanCancer Progression panel. Then, we investigated the association between the expression levels of focused genes and pathological factors in PTC patients in The Cancer Genome Atlas (TCGA) database. Results: The expression levels of 14 genes in the high-risk PTC specimens were more than two-fold those in the low-risk PTC specimens. In the TCGA database, expression levels of four genes (CCL11, COL6A3, INHBA, and SRPX2) were significantly higher in patients with advanced PTC. Among the patients with advanced PTC, those with high SRPX2 expression levels had poor disease-free survival. Univariate and multivariate analyses revealed that high SRPX2 expression was an independent prognostic factor. Conclusion: Based on the findings of this study, CCL11, COL6A3, INHBA, and SRPX2 are potential biomarkers that indicate advanced PTC. SRPX2, in particular, is considered a prognostic biomarker.

    DOI: 10.1007/s00595-021-02262-0

    Web of Science

    Scopus

    PubMed

  17. 高リスク乳頭癌の遺伝子発現プロファイリング解明を目指した研究

    柴田 雅央, 稲石 貴弘, 一川 貴洋, 添田 郁美, 高野 悠子, 武内 大, 角田 伸行, 菊森 豊根

    日本内分泌学会雑誌   Vol. 97 ( 0 ) page: 31 - 33   2021

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:一般社団法人 日本内分泌学会  

    DOI: 10.1507/endocrine.97.S.Update_31

  18. MZB1 expression indicates poor prognosis in estrogen receptor-positive breast cancer.

    Watanabe M, Shibata M, Inaishi T, Ichikawa T, Soeda I, Miyajima N, Takano Y, Takeuchi D, Tsunoda N, Kanda M, Kikumori T, Kodera Y, Nagino M

    Oncology letters   Vol. 20 ( 5 ) page: 198   2020.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/ol.2020.12059

    Scopus

    PubMed

  19. Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard Chemotherapy.

    Shibata M, Ooki A, Inokawa Y, Sadhukhan P, Ugurlu MT, Izumchenko E, Munari E, Bogina G, Rudin CM, Gabrielson E, Singh A, Hoque MO

    Molecular cancer therapeutics     2020.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1158/1535-7163.MCT-20-0024

    PubMed

  20. Clinical outcomes of neoadjuvant chemotherapy for patients with breast cancer: Tri-weekly nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide: a retrospective observational study

    Shizuku Masato, Shibata Masahiro, Shimizu Yoshimi, Takeuchi Dai, Mizuno Yutaka

    NAGOYA JOURNAL OF MEDICAL SCIENCE   Vol. 82 ( 3 ) page: 457-467   2020.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18999/nagjms.82.3.457

    Web of Science

    Scopus

  21. Measurement of the AST to LD ratio in parathyroid tissue suspension can precisely differentiate a hyperfunctioning parathyroid.

    Kikumori T, Ichikawa T, Inaishi T, Miyajima N, Shibata M, Takeuchi D

    The Journal of clinical endocrinology and metabolism     2020.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1210/clinem/dgaa264

    PubMed

  22. Utility of urinary type I collagen cross-linked N-telopeptide as a prognostic indicator in breast cancer patients with bone metastases.

    Shizuku M, Shibata M, Okumura M, Takeuchi D, Kikumori T, Mizuno Y

    Breast cancer (Tokyo, Japan)     2020.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12282-020-01109-9

    PubMed

  23. Robust, quick, and convenient intraoperative method to differentiate parathyroid tissue.

    Kikumori T, Inaishi T, Miyajima N, Shibata M, Takeuchi D

    Surgery   Vol. 167 ( 2 ) page: 385-389   2020.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.surg.2019.09.025

    Scopus

    PubMed

  24. Retrospective analysis of active surveillance for papillary thyroid microcarcinoma

    Ishihara Hiromasa, Inaishi Takahiro, Miyajima Noriyuki, Shibata Masahiro, Takano Yuko, Takeuchi Dai, Kikumori Toyone

    Official Journal of the Japan Association of Endocrine Surgeons and the Japanese Society of Thyroid Surgery   Vol. 36 ( 4 ) page: 231-234   2019

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.11226/jaesjsts.36.4_231

  25. Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer

    Kanda Mitsuro, Tanaka Chie, Kobayashi Daisuke, Tanaka Haruyoshi, Shimizu Dai, Shibata Masahiro, Takami Hideki, Hayashi Masamichi, Iwata Naoki, Niwa Yukiko, Yamada Suguru, Fujii Tsutomu, Nakayama Goro, Fujiwara Michitaka, Kodera Yasuhiro

    INTERNATIONAL JOURNAL OF CANCER   Vol. 139 ( 10 ) page: 2290-2298   2016.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/ijc.30286

    Web of Science

    Scopus

    PubMed

  26. Protein arginine methyltransferase 5 is associated with malignant phenotype and peritoneal metastasis in gastric cancer

    Kanda Mitsuro, Shimizu Dai, Fujii Tsutomu, Tanaka Haruyoshi, Shibata Masahiro, Iwata Naoki, Hayashi Masamichi, Kobayashi Daisuke, Tanaka Chie, Yamada Suguru, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    INTERNATIONAL JOURNAL OF ONCOLOGY   Vol. 49 ( 3 ) page: 1195-1202   2016.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3892/ijo.2016.3584

    Web of Science

    Scopus

    PubMed

  27. Neurotrophin Receptor-Interacting Melanoma Antigen-Encoding Gene Homolog is Associated with Malignant Phenotype of Gastric Cancer

    Kanda Mitsuro, Shimizu Dai, Fujii Tsutomu, Tanaka Haruyoshi, Tanaka Yuri, Ezaka Kazuhiro, Shibata Masahiro, Takami Hideki, Hashimoto Ryoji, Sueoka Satoshi, Iwata Naoki, Kobayashi Daisuke, Tanaka Chie, Yamada Suguru, Nakayama Goro, Sugimoto Hiroyuki, Koike Masahiko, Fujiwara Michitaka, Kodera Yasuhiro

    ANNALS OF SURGICAL ONCOLOGY   Vol. 23 ( Suppl 4 ) page: 532-539   2016.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1245/s10434-016-5375-0

    Web of Science

    Scopus

    PubMed

  28. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.

    Kanda M, Shimizu D, Tanaka H, Shibata M, Iwata N, Hayashi M, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y

    Oncotarget   Vol. 7 ( 12 ) page: 13667-79   2016.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.18632/oncotarget.7269

    Scopus

    PubMed

  29. Adrenocortical carcinoma

    Shibata Masahiro, Inaishi Takahiro, Miyajima Noriyuku, Adachi Yayoi, Ohnishi Eiji, Takeuchi Dai, Nakanishi Kenichi, Hayashi Hironori, Kikumori Toyone

    Official Journal of the Japan Association of Endocrine Surgeons and the Japanese Society of Thyroid Surgery   Vol. 33 ( 1 ) page: 36-40   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.11226/jaesjsts.33.1_36

  30. Unmasked renal impairment and prolonged hyperkalemia after unilateral adrenalectomy for primary aldosteronism coexisting with primary hyperparathyroidism: report of a case.

    Hibi Y, Hayakawa N, Hasegawa M, Ogawa K, Shimizu Y, Shibata M, Kagawa C, Mizuno Y, Yuzawa Y, Itoh M, Iwase K

    Surgery today   Vol. 45 ( 2 ) page: 241-6   2015.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00595-013-0813-0

    PubMed

  31. Postoperative elevation of CA15-3 due to pernicious anemia in a patient without evidence of breast cancer recurrence

    Adachi Yayoi, Kikumori Toyone, Miyajima Noriyuki, Inaishi Takahiro, Onishi Eiji, Shibata Masahiro, Nakanishi Kenichi, Takeuchi Dai, Hayashi Hironori, Kodera Yasuhiro

    SURGICAL CASE REPORTS   Vol. 1 ( 1 ) page: 126   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s40792-015-0128-z

    Web of Science

    PubMed

  32. A case of retroperitoneal bronchogenic cyst which was difficult to be differentiated from an adrenal tumor

    Shibata Masahiro, Takeuchi Dai, Nakanishi Kenichi, Hayashi Hironori, Kikumori Toyone

    Official Journal of the Japan Association of Endocrine Surgeons and the Japanese Society of Thyroid Surgery   Vol. 32 ( 3 ) page: 201-204   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.11226/jaesjsts.32.3_201

  33. Pheochromocytoma as the first manifestation of MEN2A with RET mutation S891A: report of a case.

    Hibi Y, Ohye T, Ogawa K, Shimizu Y, Shibata M, Kagawa C, Mizuno Y, Uchino S, Kosugi S, Kurahashi H, Iwase K

    Surgery today   Vol. 44 ( 11 ) page: 2195-200   2014.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00595-013-0826-8

    PubMed

  34. A MEN2A family with two asymptomatic carriers affected by unilateral renal agenesis.

    Hibi Y, Ohye T, Ogawa K, Shimizu Y, Shibata M, Kagawa C, Mizuno Y, Kurahashi H, Iwase K

    Endocrine journal   Vol. 61 ( 1 ) page: 19-23   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PubMed

  35. Increased protein kinase A type Iα regulatory subunit expression in parathyroid gland adenomas of patients with primary hyperparathyroidism.

      Vol. 60 ( 2 ) page: 215-23   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PubMed

▼display all

KAKENHI (Grants-in-Aid for Scientific Research) 1

  1. Functional analysis of YAP1 in breast cancer and development of the new therapy of "YAP1 inhibition"

    Grant number:19K16795  2019.4 - 2022.3

    Grant-in-Aid for Early-Career Scientists

      More details

    Authorship:Principal investigator 

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

 

Teaching Experience (On-campus) 6

  1. ポリクリセミナー(第2外科 乳腺・内分泌外科グループ)

    2019

  2. ポリクリセミナー(第2外科 乳腺・内分泌外科グループ)

    2020

  3. ポリクリ 外科ユニット 乳腺・内分泌外科レクチャー

    2022

  4. ポリクリ 外科ユニット 乳腺・内分泌外科レクチャー

    2021

  5. 内分泌・代謝

    2020

  6. ポリクリセミナー(第2外科 乳腺・内分泌外科グループ)

    2018

     詳細を見る

    2週間に1回、各ポリクリグループの学生を対象に、乳腺・内分泌外科疾患に関する講義と頸部エコーや細胞診のハンズオンを行っている。

▼display all